These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9730972)

  • 21. Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms.
    Sabina RL; Mahnke-Zizelman DK
    Pharmacol Ther; 2000; 87(2-3):279-83. PubMed ID: 11008004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive and negative elements mediate control of alternative splicing in the AMPD1 gene.
    Morisaki H; Morisaki T; Kariko K; Genetta T; Holmes EW
    Gene; 2000 Apr; 246(1-2):365-72. PubMed ID: 10767559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
    BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMPD1: a novel therapeutic target for reversing insulin resistance.
    Cheng J; Morisaki H; Toyama K; Sugimoto N; Shintani T; Tandelilin A; Hirase T; Holmes EW; Morisaki T
    BMC Endocr Disord; 2014 Dec; 14():96. PubMed ID: 25511531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
    Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
    Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining structure/function relationships for sarcomeric myosin heavy chain by genetic and transgenic manipulation of Drosophila.
    Swank DM; Wells L; Kronert WA; Morrill GE; Bernstein SI
    Microsc Res Tech; 2000 Sep; 50(6):430-42. PubMed ID: 10998634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of DYNLL2 to myosin Va requires alternatively spliced exon B and stabilizes a portion of the myosin's coiled-coil domain.
    Wagner W; Fodor E; Ginsburg A; Hammer JA
    Biochemistry; 2006 Sep; 45(38):11564-77. PubMed ID: 16981716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of genetically expressed cardiac titin fragments on in vitro actin motility.
    Li Q; Jin JP; Granzier HL
    Biophys J; 1995 Oct; 69(4):1508-18. PubMed ID: 8534821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
    Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
    Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient.
    Morisaki H; Higuchi I; Abe M; Osame M; Morisaki T
    Hum Mutat; 2000 Dec; 16(6):467-72. PubMed ID: 11102975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel pathway for alternative splicing: identification of an RNA intermediate that generates an alternative 5' splice donor site not present in the primary transcript of AMPD1.
    Mineo I; Clarke PR; Sabina RL; Holmes EW
    Mol Cell Biol; 1990 Oct; 10(10):5271-8. PubMed ID: 2398891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine tuning a molecular motor: the location of alternative domains in the Drosophila myosin head.
    Bernstein SI; Milligan RA
    J Mol Biol; 1997 Aug; 271(1):1-6. PubMed ID: 9300050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site.
    Mangani S; Benvenuti M; Moir AJ; Ranieri-Raggi M; Martini D; Sabbatini AR; Raggi A
    Biochim Biophys Acta; 2007 Feb; 1774(2):312-22. PubMed ID: 17254852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternatively spliced exon B of myosin Va is essential for binding the tail-associated light chain shared by dynein.
    Hódi Z; Németh AL; Radnai L; Hetényi C; Schlett K; Bodor A; Perczel A; Nyitray L
    Biochemistry; 2006 Oct; 45(41):12582-95. PubMed ID: 17029413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles.
    Prado LG; Makarenko I; Andresen C; Krüger M; Opitz CA; Linke WA
    J Gen Physiol; 2005 Nov; 126(5):461-80. PubMed ID: 16230467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.
    Tarnopolsky MA; Parise G; Gibala MJ; Graham TE; Rush JW
    J Physiol; 2001 Jun; 533(Pt 3):881-9. PubMed ID: 11410643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myosin individualized: single nucleotide polymorphisms in energy transduction.
    Burghardt TP; Neff KL; Wieben ED; Ajtai K
    BMC Genomics; 2010 Mar; 11():172. PubMed ID: 20226094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered kinetics of AMP deaminase by myosin binding.
    Rundell KW; Tullson PC; Terjung RL
    Am J Physiol; 1992 Aug; 263(2 Pt 1):C294-9. PubMed ID: 1514576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Family of AMP-deaminase genes].
    Szydłowska M
    Postepy Hig Med Dosw (Online); 2005; 59():503-9. PubMed ID: 16258416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.
    Admyre T; Amrot-Fors L; Andersson M; Bauer M; Bjursell M; Drmota T; Hallen S; Hartleib-Geschwindner J; Lindmark B; Liu J; Löfgren L; Rohman M; Selmi N; Wallenius K
    Chem Biol; 2014 Nov; 21(11):1486-96. PubMed ID: 25459661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.